Skip to content

Effects of propranolol on labor

Effects of propranolol on duration of labor in women with rupture of membranes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201211108151N4
Enrollment
140
Registered
2013-05-20
Start date
2016-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

duration of labor. long labour

Interventions

Intervention 1: 2 mg propranolol before oxytocin ( intervention group ). Intervention 2: normal saline as placebo before oxytocin ( control group ).
Treatment - Drugs
2 mg propranolol before oxytocin ( intervention group )
normal saline as placebo before oxytocin ( control group )

Sponsors

Shahid Beheshti University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: GA>34 w; singleton pregnancy; cephalic presentation; no contraindication of vaginal delivery;cervical dilatation 60 per minutes; no history of uterine scar; patient inform consent. Exclusion criteria: lack of consent at every stage of research.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Duration of labor. Timepoint: from induction of labor to delivery. Method of measurement: minutes.

Secondary

MeasureTime frame
Cesarean rate. Timepoint: at the last of study. Method of measurement: hospital documents.;Neonatal Apgar. Timepoint: first and fifth minutes. Method of measurement: Apgar score.;Fetal complications. Timepoint: at the last of study. Method of measurement: physical exam.;Maternal complications. Timepoint: at the last of study. Method of measurement: history - physical exam.;Oxytocin dosage. Timepoint: at the last of study. Method of measurement: hospital documents.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Nazari

Shahid Beheshti University of Medical Science

leynaz@yahoo.com+98 21 2218 1693

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026